Health officials are warning about the rise of multiple infections this season — especially among school-aged children — including whooping cough and walking pneumonia.
A team led by US Food and Drug Administration (FDA) researchers studying Medicare claims data during the early Omicron SARS-CoV-2 variant months conclude that a third dose of mRNA COVID-19 vaccine provides significant protection against hospitalization and death compared with two doses but wanes substantially after 4 months.
Recent Comments